Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockadeJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62023-05-088OAAI
A REPRODUCIBLE PIPELINE FOR ANALYSIS OF MULTIPLEX IMAGING (MIBI) DATA WITH APPLICATION TO UNCOVERING NOVEL FEATURES OF THE TUMORIMMUNE MICROENVIRONMENTJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-070OA
A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without IpilimumabCLINICAL CANCER RESEARCHIF10.22019-04-0172OAAI
Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell PopulationsCLINICAL CANCER RESEARCHIF10.22018-11-01265OAAI
Antigen Presentation Keeps Trending in Immunotherapy ResistanceCLINICAL CANCER RESEARCHIF10.22018-07-159OAAI
Accelerated wound healing by injectable star poly(ethylene glycol)-b-poly (propylene sulfide) scaffolds loaded with poorly water-soluble drugsJOURNAL OF CONTROLLED RELEASEIF11.52018-07-0136OAAI
T-cell responses to survivin in cancer patients undergoing radiation therapyCLINICAL CANCER RESEARCHIF10.22008-08-01125OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向